Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
13.54
-0.07 (-0.51%)
Nov 17, 2026, 3:04 PM CST

SHE:300122 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
2,3192,6262,7066,3412,6224,308
Trading Asset Securities
--11.53---
Cash & Short-Term Investments
2,3192,6262,7176,3412,6224,308
Cash Growth
-7.16%-3.37%-57.15%141.81%-39.13%199.68%
Accounts Receivable
9,95411,16516,30227,05920,61412,868
Other Receivables
38.56148.1210.977.88.396.87
Receivables
9,99211,31316,31327,06620,62212,874
Inventory
2,0035,00322,2448,9868,0207,385
Prepaid Expenses
-0.144.919.73-0.59
Other Current Assets
177.0777.16124.31111.37148.53185.63
Total Current Assets
14,49119,01941,40342,51431,41324,754
Property, Plant & Equipment
5,5025,8806,1655,1204,6933,557
Long-Term Investments
289.35289.35295295284.5239
Goodwill
19.2819.2819.2819.2819.2819.28
Other Intangible Assets
771.38574.48346.25317.68352.71342.8
Long-Term Deferred Tax Assets
3,8963,697966.88569.19186.08115.34
Long-Term Deferred Charges
2,0152,0901,8711,088731.97485.04
Other Long-Term Assets
147.72150.07231.11308.42322.5534.91
Total Assets
27,13231,72051,29750,23238,00430,047

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
1,6161,2415,82313,1429,8079,178
Accrued Expenses
70.53578.71522.161,6731,2401,090
Short-Term Debt
1.248,59411,9022,6351,785568.86
Current Portion of Long-Term Debt
2,150765.6285.0136.41--
Current Portion of Leases
-9.211.7710.29.810.25
Current Income Taxes Payable
9.756.5386.86434.59347.7933.25
Current Unearned Revenue
38.7583.411.8711.31--
Other Current Liabilities
1,0761,125418.82143.8640.1799.62
Total Current Liabilities
4,96212,40418,86118,08613,23011,871
Long-Term Debt
6,4812,9091,242328.08210.64236.41
Long-Term Leases
13.919.5416.6725.3127.7612.24
Long-Term Unearned Revenue
243.74256.05281.68228.27238.34222.2
Long-Term Deferred Tax Liabilities
29.635.6644.3157.9660.7748.34
Total Liabilities
11,73115,61420,44618,72613,76812,390

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
2,3942,3942,3942,4001,6001,600
Additional Paid-In Capital
210.19210.19197.8847.96207.96207.96
Retained Earnings
12,55313,23628,26229,05822,42815,849
Total Common Equity
15,15715,84030,85431,50624,23617,657
Minority Interest
244.59266.35-2.23---
Shareholders' Equity
15,40116,10630,85131,50624,23617,657
Total Liabilities & Equity
27,13231,72051,29750,23238,00430,047

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
8,64612,28713,2573,0352,033817.76
Net Cash (Debt)
-6,327-9,662-10,5403,305588.943,490
Net Cash Growth
---461.19%-83.13%-
Net Cash Per Share
-2.64-4.04-4.401.380.251.45
Filing Date Shares Outstanding
2,3942,3942,3942,4002,4002,400
Total Common Shares Outstanding
2,3942,3942,3942,4002,4002,400
Working Capital
9,5296,61522,54224,42818,18312,883
Book Value Per Share
6.336.6212.8913.1310.107.36
Tangible Book Value
14,36615,24630,48831,16923,86417,295
Tangible Book Value Per Share
6.006.3712.7412.999.947.21
Buildings
-2,8802,8402,5221,7051,042
Machinery
-3,6053,3962,5262,0641,369
Construction In Progress
-1,5471,5851,2871,8361,825